Clinical Trial Of Drug To Prevent Excessive Bleeding After Childbirth Set To Begin

The Guardian: Drug to prevent excessive bleeding after childbirth could save thousands of lives
“The trial of a new drug to prevent excessive bleeding in women after childbirth, which could potentially save thousands of lives annually, is to begin in 12 countries in June…” (Ford, 4/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.